Drug application
SERTRALINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE)
Drugs@FDA ANDA 078053 · RANBAXY LABS LTD
Key facts
| Drug name | SERTRALINE HYDROCHLORIDE |
|---|---|
| Active ingredients | SERTRALINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 078053 |
| Company | RANBAXY LABS LTD |
| Dosage forms | CONCENTRATE, ORAL |
| Strength | EQ 20MG BASE/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Nov 30, 2006 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.